Anti-NAT8L monoclonal antibody
Pre-made anti-NAT8L monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to NAT8L/NAT8L products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP1236-Ab-1/ GM-Tg-hg-IP1236-Ab-2 | Anti-Human NAT8L monoclonal antibody | Human |
GM-Tg-rg-IP1236-Ab-1/ GM-Tg-rg-IP1236-Ab-2 | Anti-Rat NAT8L monoclonal antibody | Rat |
GM-Tg-mg-IP1236-Ab-1/ GM-Tg-mg-IP1236-Ab-2 | Anti-Mouse NAT8L monoclonal antibody | Mouse |
GM-Tg-cynog-IP1236-Ab-1/ GM-Tg-cynog-IP1236-Ab-2 | Anti-Cynomolgus/ Rhesus macaque NAT8L monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP1236-Ab-1/ GM-Tg-felg-IP1236-Ab-2 | Anti-Feline NAT8L monoclonal antibody | Feline |
GM-Tg-cang-IP1236-Ab-1/ GM-Tg-cang-IP1236-Ab-2 | Anti-Canine NAT8L monoclonal antibody | Canine |
GM-Tg-bovg-IP1236-Ab-1/ GM-Tg-bovg-IP1236-Ab-2 | Anti-Bovine NAT8L monoclonal antibody | Bovine |
GM-Tg-equg-IP1236-Ab-1/ GM-Tg-equg-IP1236-Ab-2 | Anti-Equine NAT8L monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP1236-Ab-1/ GM-Tg-hg-IP1236-Ab-2; GM-Tg-rg-IP1236-Ab-1/ GM-Tg-rg-IP1236-Ab-2; GM-Tg-mg-IP1236-Ab-1/ GM-Tg-mg-IP1236-Ab-2; GM-Tg-cynog-IP1236-Ab-1/ GM-Tg-cynog-IP1236-Ab-2; GM-Tg-felg-IP1236-Ab-1/ GM-Tg-felg-IP1236-Ab-2; GM-Tg-cang-IP1236-Ab-1/ GM-Tg-cang-IP1236-Ab-2; GM-Tg-bovg-IP1236-Ab-1/ GM-Tg-bovg-IP1236-Ab-2; GM-Tg-equg-IP1236-Ab-1/ GM-Tg-equg-IP1236-Ab-2 |
Products Name | Anti-NAT8L monoclonal antibody |
Format | mab |
Target Name | NAT8L |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-NAT8L monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP1236-Ag-1 | Recombinant multi-species NAT8L/ CML3/ NACED protein |
Target information
Target ID | GM-IP1236 |
Target Name | NAT8L |
Gene ID | 339983,269642,289727,722359,612955,101083676,614317,100052893 |
Gene Symbol and Synonyms | 1110038O08Rik,CML3,NACED,NAT8-LIKE,NAT8L,RGD1305719,Shati |
Uniprot Accession | Q8N9F0,D3ZVU9 |
Uniprot Entry Name | NAT8L_HUMAN,NAT8L_RAT |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000185818 |
Target Classification | N/A |
The target: NAT8L, gene name: NAT8L, also named as CML3, NACED, NAT8-LIKE. This gene encodes a single-pass membrane protein, which contains a conserved sequence of the GCN5 or NAT superfamily of N-acetyltransferases and is a member of the N-acyltransferase (NAT) superfamily. This protein is a neuron-specific protein and is the N-acetylaspartate (NAA) biosynthetic enzyme, catalyzing the NAA synthesis from L-aspartate and acetyl-CoA. NAA is a major storage and transport form of acetyl coenzyme A specific to the nervous system. The gene mutation results in primary NAA deficiency (hypoacetylaspartia). [provided by RefSeq, Dec 2010].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.